Uterine sarcoma. Clinico-pathological characteristics and outcome

Area of Science:

• Gynecologic Oncology
• Surgical Pathology
• Clinical Oncology

Background:

• Uterine sarcoma is a rare and aggressive malignancy of the female reproductive system.
• Understanding its clinical and histopathological features is crucial for effective management.

Purpose of the Study:

• To analyze the clinical and histopathological characteristics of uterine sarcoma.
• To identify prognostic factors, treatment outcomes, relapse patterns, and survival rates.

Main Methods:

• Retrospective review of 36 uterine sarcoma patients diagnosed between 2000 and 2012.
• Data collected included patient demographics, tumor histology, staging, treatment, and follow-up.

Main Results:

• Carcinosarcoma was the most common type (58%). Most patients presented with advanced stages (III/IV).
• Advanced stages and lymphovascular invasion were associated with poor disease-free survival (DFS).
• Chemotherapy significantly improved DFS (p=0.027), while the 2-year DFS rate was 22% and 5-year DFS was 14%.

Conclusions:

• High-grade uterine sarcoma has a poor prognosis, with a 2-year survival rate of approximately 30%.
• Advanced stage and lymphovascular invasion are key negative prognostic indicators.
• More aggressive treatment strategies are needed to improve outcomes for uterine sarcoma patients.